Literature DB >> 24415155

Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.

Benjamin R Smith1, Marta B Santos, Michael S Marshall, Ludovico Cantuti-Castelvetri, Aurora Lopez-Rosas, Guannan Li, Richard van Breemen, Kumiko I Claycomb, Jose I Gallea, Maria S Celej, Stephen J Crocker, Maria I Givogri, Ernesto R Bongarzone.   

Abstract

Demyelination is a major contributor to the general decay of neural functions in children with Krabbe disease. However, recent reports have indicated a significant involvement of neurons and axons in the neuropathology of the disease. In this study, we have investigated the nature of cellular inclusions in the Krabbe brain. Brain samples from the twitcher mouse model for Krabbe disease and from patients affected with the infantile and late-onset forms of the disease were examined for the presence of neuronal inclusions. Our experiments demonstrated the presence of cytoplasmic aggregates of thioflavin-S-reactive material in both human and murine mutant brains. Most of these inclusions were associated with neurons. A few inclusions were detected to be associated with microglia and none were associated with astrocytes or oligodendrocytes. Thioflavin-S-reactive inclusions increased in abundance, paralleling the development of neurological symptoms, and distributed throughout the twitcher brain in areas of major involvement in cognition and motor functions. Electron microscopy confirmed the presence of aggregates of stereotypic β-sheet folded proteinaceous material. Immunochemical analyses identified the presence of aggregated forms of α-synuclein and ubiquitin, proteins involved in the formation of Lewy bodies in Parkinson's disease and other neurodegenerative conditions. In vitro assays demonstrated that psychosine, the neurotoxic sphingolipid accumulated in Krabbe disease, accelerated the fibrillization of α-synuclein. This study demonstrates the occurrence of neuronal deposits of fibrillized proteins including α-synuclein, identifying Krabbe disease as a new α-synucleinopathy.
Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  Krabbe disease; Lewy bodies; axonal degeneration; dying-back pathology; myelin; psychosine; synucleinopathies; ubiquitin; α-synuclein

Mesh:

Substances:

Year:  2014        PMID: 24415155      PMCID: PMC3977150          DOI: 10.1002/path.4328

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  88 in total

1.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.

Authors:  G Lennox; J Lowe; M Landon; E J Byrne; R J Mayer; R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

3.  Thalamic hyperdensity: a previously unreported sign of Sandhoff disease.

Authors:  H P Stalker; B K Han
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

4.  The peripheral neuropathy of canine globoid-cell leukodystrophy (krabbe-type).

Authors:  H J Kurtz; T F Fletcher
Journal:  Acta Neuropathol       Date:  1970       Impact factor: 17.088

5.  Krabbe's disease: clinical presentation of neurological variants.

Authors:  B Hagberg
Journal:  Neuropediatrics       Date:  1984-09       Impact factor: 1.947

6.  Clinical and cerebral FDG PET scan in a patient with Krabbe's disease.

Authors:  M A Al-Essa; S M Bakheet; Z J Patay; J E Powe; P T Ozand
Journal:  Pediatr Neurol       Date:  2000-01       Impact factor: 3.372

Review 7.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

8.  Identification of two distinct synucleins from human brain.

Authors:  R Jakes; M G Spillantini; M Goedert
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

9.  The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease).

Authors:  T Kobayashi; T Yamanaka; J M Jacobs; F Teixeira; K Suzuki
Journal:  Brain Res       Date:  1980-12-08       Impact factor: 3.252

Review 10.  The neuropathology, pathophysiology and genetics of multiple system atrophy.

Authors:  Z Ahmed; Y T Asi; A Sailer; A J Lees; H Houlden; T Revesz; J L Holton
Journal:  Neuropathol Appl Neurobiol       Date:  2012-02       Impact factor: 8.090

View more
  46 in total

1.  Coupling of the non-amyloid-component (NAC) domain and the KTK(E/Q)GV repeats stabilize the α-synuclein fibrils.

Authors:  Liang Xu; Ruth Nussinov; Buyong Ma
Journal:  Eur J Med Chem       Date:  2016-01-25       Impact factor: 6.514

Review 2.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathies.

Authors:  Michael S Marshall; Ernesto R Bongarzone
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 4.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

5.  Mechanism of neuromuscular dysfunction in Krabbe disease.

Authors:  Ludovico Cantuti-Castelvetri; Erick Maravilla; Michael Marshall; Tammy Tamayo; Ludovic D'auria; John Monge; James Jeffries; Tuba Sural-Fehr; Aurora Lopez-Rosas; Guannan Li; Kelly Garcia; Richard van Breemen; Charles Vite; Jesus Garcia; Ernesto R Bongarzone
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

Review 6.  α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.

Authors:  Rui Wang; Hongyang Sun; Haigang Ren; Guanghui Wang
Journal:  Sci China Life Sci       Date:  2020-07-15       Impact factor: 6.038

7.  Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.

Authors:  Myung Jong Kim; Sohee Jeon; Lena F Burbulla; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

8.  Long-Term Improvement of Neurological Signs and Metabolic Dysfunction in a Mouse Model of Krabbe's Disease after Global Gene Therapy.

Authors:  Michael S Marshall; Yazan Issa; Benas Jakubauskas; Monika Stoskute; Vince Elackattu; Jeffrey N Marshall; Wil Bogue; Duc Nguyen; Zane Hauck; Emily Rue; Subha Karumuthil-Melethil; Violeta Zaric; Maarten Bosland; Richard B van Breemen; Maria I Givogri; Steven J Gray; Stephen J Crocker; Ernesto R Bongarzone
Journal:  Mol Ther       Date:  2018-01-17       Impact factor: 11.454

9.  Aberrant production of tenascin-C in globoid cell leukodystrophy alters psychosine-induced microglial functions.

Authors:  Kumiko I Claycomb; Paige N Winokur; Kasey M Johnson; Alexandra M Nicaise; Anthony W Giampetruzzi; Anthony V Sacino; Evan Y Snyder; Elisa Barbarese; Ernesto R Bongarzone; Stephen J Crocker
Journal:  J Neuropathol Exp Neurol       Date:  2014-10       Impact factor: 3.685

10.  Is Parkinson's disease a lysosomal disorder?

Authors:  Andrés D Klein; Joseph R Mazzulli
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.